Polarean, Inc.

XENOVIEW

Manufacturer:

Polarean, Inc.

Xenoview HCPCS:

C9150

HCPCS Code Descriptor:

Xenon xe-129 hyperpolarized gas, diagnostic, per study dose

Category:

C Code

Xenoview NDCs:

Primary Type:

Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Route of Administration:

Inhalation

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Xenoview:

XENOVIEW is a Radiopharmaceutical drug manufactured by Polarean, Inc. and administered via the Inhalation route of administration. The C Code: C9150 is aligned to the drug XENOVIEW.

ACCESS PRICING AND MORE BY REGISTERING

C9150 Added Date:

July 1, 2023

C9150 Effective Date:

July 1, 2023

C9150 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Xenoview billing and coding information.
Our team did not identify a source for Xenoview patient assistance information. Please reach out to our team if you feel that this is a mistake.
XENOVIEW prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for XENOVIEW. Please check back in a few weeks.